切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2021, Vol. 09 ›› Issue (03) : 174 -181. doi: 10.3877/cma.j.issn.2095-5820.2021.03.010

综述

新型冠状病毒及其分子生物学诊断新技术
朱镭1, 朱庆义2,()   
  1. 1. 030013 山西太原,山西省儿童医院
    2. 030032 山西太原,太原金域临床检验所
  • 收稿日期:2020-11-03 出版日期:2021-08-28
  • 通信作者: 朱庆义

Novel coronavirus and molecular diagnostic technique

Lei Zhu1, Qingyi Zhu2,()   

  1. 1. Shanxi Children?s Hospital, Taiyuan Shanxi 030013, China
    2. Taiyuan KingMed Center for Clinical Laboratory, Taiyuan Shanxi 030032, China
  • Received:2020-11-03 Published:2021-08-28
  • Corresponding author: Qingyi Zhu
引用本文:

朱镭, 朱庆义. 新型冠状病毒及其分子生物学诊断新技术[J]. 中华临床实验室管理电子杂志, 2021, 09(03): 174-181.

Lei Zhu, Qingyi Zhu. Novel coronavirus and molecular diagnostic technique[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2021, 09(03): 174-181.

冠状病毒(Corona virus)为正向单链RNA病毒,目前已知引起人类疾病的冠状病毒有7种。新型冠状病毒(SARS-CoV-2)为β属冠状病毒,主要引起新型冠状病毒肺炎(COVID-19)。目前,COVID-19在世界范围内快速传播和蔓延,已成为一种常态化防控的新发传染病。本文对SARS-CoV-2的基因分型和实验室诊断新技术,包括实时荧光定量聚合酶链反应(FQ-PCR)、环介导等温扩增(LAMP),POCT免疫层析快速诊断试验,核酸质谱分析(MALDI-TOF)和基因测序等作了简要概述。

Corona virus is a plus-single-stranded RNA virus, and currently there are 7 types of coronavirus known to cause diseases in human. Novel coronavirus (SARS-CoV-2) is a β genus coronavirus and mainly causes novel coronavirus pneumonia. At present, COVID-19 is rapidly spreading around the world and has become an emerging infectious diseases under regular prevention and control. In this paper, new techniques for genotyping and laboratory diagnosis of SARS-CoV-2, including real-time fluorescent quantitative polymerase chain reaction (FQ-PCR), loop-mediated isothermal amplification (LAMP), rapid diagnostic test of POCT immunochromatography, nucleic acid mass spectrometry (MALDI-TOF) and gene sequencing, were briefly reviewed.

表1 WHO报告各机构建立PCR法检测SARS-CoV-2的基因位点
表2 WHO报告各机构采用PCR试验检测SARS-CoV-2基因位点及其引物设计
表3 ORF 1ab和N基因引物和探针序列
表4 COVID-19 RT-LAMP检测法引物序列
1
Dhama K, , Khan S, Tiwari R,et al. Coronavirus Disease 2019-COVID-19[J]. Clin Microbiol Rev, 2020;33(4):e00028-20.
2
Zhu N, Zhang D, Wang W, et al. A Novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020. 382, 727-733.
3
Ge XY, Li JL, Yang XL, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor[J]. Nature, 2013, 503:535-538.
4
WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020.

URL    
5
Woo PC, Lau SK, Lam CS, et al. Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus[J]. J Virol 2012, 86:3995-4008.
6
Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China[J]. N Engl J Med, 2020, 382(18):1708-1720.
7
Ge H, Wang X, Yuan X, et al. The epidemiology and clinical information about COVID-19[J]. Eur J Clin Microbiol Infect Dis, 2020 Jun;39(6):1011-1019.
8
Wu F, Zhao S, Yu B,et al. A new coronavirus associated with human respiratory disease in China[J]. Nature, 2020, 579(3):265-269.
9
Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2[J]. Gene Rep, 2020, 19:100682.
10
Zhang C, Zheng W, Huang X, et al. Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1[J]. J Proteome Res, 2020, 19(4):1351-1360.
11
Rabaan AA, Al-Ahmed SH, Haque S, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV: a comparative overview[J]. Infez Med, 2020, 28(2):174-184.
12
Li F. Structure, function, and evolution of coronavirus spike proteins[J]. Annu Rev Virol, 2016, 3:237-261.
13
World Health Organization. Molecular assays to diagnose COVID-19: Summary table of available protocols. 2020.

URL    
14
Udugama B, Kadhiresan P, Kozlowski HN, et al. Diagnosing COVID-19: The Disease and Tools for Detection[J]. ACS Nano, 2020, 14(4):3822-3835.
15
Li Y, Yao L, Li J, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19[J]. J Med Virol, 2020, 92(7):903-908.
16
Ren LL, Wang YM, Wu ZQ, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study[J]. Chin Med J, 2020, 133:1015-1024.
17
Yip CC, Sridhar S, Leung KH, et al. Development and Evaluation of Novel and Highly Sensitive Single-Tube Nested Real-Time RT-PCR Assays for SARS-CoV-2 Detection[J]. Int J Mol Sci, 2020, 21(16):5674.
18
郭元元, 王昆, 张宇, 等. 6种国产新型冠状病毒核酸检测试剂检测性能比较与分析[J]. 重庆医学, 2020, 49(15):2435-2439.
19
Chu DKW, Pan Y, Cheng SMS, et al. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia[J]. Clin Chem, 2020, 66(4): 549-555.
20
陈炜, 张春阳, 朱颖, 等. 4例新型冠状病毒感染病例咽拭子与痰标本病毒核酸检测的比较[J]. 中国人兽共患病学报, 2020, 36(5):354-358.
21
Lu R, Wu X, , Wan Z, et al. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2[J]. Int J Mol Sci, 2020, 18;21(8): 2826.
22
Shirato K, Semba S, Kafrawy SA, et al. Development of fluorescent reverse transcription loopmediated isothermal amplification (RT-LAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus[J]. J Virol Methods, 2018, 258: 41-8.
23
Rocca MF, Zintgraff JC, Dattero ME, et al. A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs[J]. J Virol Methods, 2020, 286:113991.
24
Xiu L,Zhang C,Wu Z. Establishment and Application of a Universal Coronavirus Screening Method using MALDI-TOF mass spectrometry[J]. Front Microbiol, 2017, 8:1510.
25
王俊, 张栋, 陈晴晴, 等. PCR-核酸飞行时间质谱系统检测新型冠状病毒方法的建立及应用研究[J]. 中国全科医学, 2020, 23(35):4430-4435.
26
Yang T, Wang YC, Shen CF, et al. Point-of-care RNA-based diagnostic device for COVID-19[J]. Diagnostics, 2020, 10:165.
27
Wolters F, van de Bovenkamp J, van den Bosch B, et al. Multi-center evaluation of cepheid xpert xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic[J]. J Clin Virol, 2020, 128:104426.
28
Augustine R, Hasan A, Suvarthi Das S, et al. Loop-Mediated Isothermal Amplification (LAMP): A Rapid, Sensitive, Specific, and Cost-Effective Point-of-Care Test for Corona-viruses in the Context of COVID-19 Pandemic[J]. Biology (Basel), 2020, 9(8):182.
29
邓均, 宋世平, 郑峻松. 我国POCT发展现状与展望[J]. 临床检验杂志, 2015, 33(11):844-845.
30
Wang H, Li X, Li T, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2[J]. Eur J Clin Microbiol Infect Dis, 2020, 39:1629-1635.
31
Lu R, Zhao X, Li J, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding[J]. Lancet, 2020, 395(10224): 565-574.
32
Chen L, Liu W, Zhang Q, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak[J]. Emerg Microbes Infect, 2020, 9(1): 313-9.
33
Di L, Fu Y, Sun Y, et al. RNA sequencing by direct tagmentation of RNA/DNA hybrids[J]. Proc Natl Acad Sci USA, 2020, 117(6): 2886-93.
34
Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan[J]. Emerg Microbes Infect, 2020, 9:221-236
35
Kirby T. New variant of SARS-CoV-2 in UK causes surge of COVID-19[J]. Lancet Respir Med, 2021, S2213-2600(21)00005-9.
36
Li B, Si HR, Zhu Y, et al. Discovery of bat coronaviruses through surveillance and probe capture-based next-generation sequencing[J]. MSphere, 2020, 5: e00807-19.
37
李梦婷, 祝小荐, 万绍贵. 高通量基因测序技术在新型冠状病毒检测中的应用[J]. 赣南医学院学报, 2020, 40(03):225-228.
38
Chan WM, Ip JD, Chu AW, et al. Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole-genome sequencing[J]. J Med Virol, 2020, 92(11):2725-2734.
[1] 康一坤, 袁芃. 三阴性乳腺癌分子遗传学及临床特征研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 290-293.
[2] 王雪菲, 海琳悦, 李立方, 肖春花. Luminal A型乳腺癌的内分泌治疗与化疗[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 294-300.
[3] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[4] 罗丹, 孔为民, 陈姝宁, 赵小玲, 谢云凯. 子宫内膜异位症患者在位及异位内膜上皮细胞-间充质转化相关生物标志物的变化[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 530-539.
[5] 李维, 莫俊俏. 儿童呼吸道耐药流感嗜血杆菌基因型鉴定及耐药分析对抗菌药物治疗选择的意义[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 315-323.
[6] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[7] 黄威, 刘启, 陈流华, 滕茶香, 区喆建, 刘韩笑, 陈健聪, 张昆松. 新定义的可预测肝癌预后的焦亡相关lncRNA模型[J]. 中华普通外科学文献(电子版), 2023, 17(05): 357-365.
[8] 袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[9] 樊丽超, 郭瑾瑛, 陈鑫. 野生型RET与RET/PTC融合基因检测对甲状腺乳头状癌中央区淋巴结清扫的指导意义[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 631-635.
[10] 彭雨诗, 苗芸, 严紫嫣. 宏基因组高通量测序诊断肾移植术后华支睾吸虫感染一例[J]. 中华移植杂志(电子版), 2023, 17(05): 297-299.
[11] 刘恒, 侯宇川. 膀胱癌新型灌注药物的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 445-451.
[12] 许丁伟, 马江云, 李新成, 黄洁. Alagille综合征疑诊为先天性胆道闭锁一例并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 681-687.
[13] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[14] 王飞飞, 王光林, 孟泽松, 李保坤, 曹龙飞, 张娟, 周超熙, 丁源一, 王贵英. 敲低IMPDH1对结肠癌SW480、HT29细胞生物功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(08): 884-890.
[15] 高红琴, 陈晨, 陆瑞科, 王小雨, 张敏, 李少华, 郝梨岚, 黄新程, 关凌耀, 张韵红. 外阴阴道假丝酵母菌病对女性阴道-宫颈菌群的影响研究[J]. 中华临床医师杂志(电子版), 2023, 17(06): 720-725.
阅读次数
全文


摘要